Detailed Information

SNP ID FP0000141 Gene Symbol ABCG2 Chromosome 4q22 Original ID MPJ6_AG2018 rs2231153 ssj0001939 Site Intron 11 Reference Sequence NT_016354.17 Position 1 13517067 Position 2 77761 Position 3 7737297 Position 4 IVS11+20 Obserbed A/G 5'-Flanking AACTCTTTGTGGTAGAGAAGAAGCTCTTCATGTGAGTAGGTCTTTGTTCT 3'-Flanking GGAACGGGGCTGTCCAGCAGCAGGGGCTATTGGTTAGACTGATTACATCT Effect Frequency 57/354 Method Sequencing 1st Forward Primer ABCG2-11F1 ACCAGAACAGTTTCCCTTTT 1st Reverse Primer ABCG2-11R AAAAGTACTGGTAATCCTCCG SQ Forward Primer ABCG2-11F CCCTTTTTTTCCTGCTTAAC SQ Reverse Primer ABCG2-11R2 AACCCCAGATGTAATCAGTC Reference 1 Wang et al., 2003, Ann Hum Genet., 68, 563-573; Bosch et al., 2005, Am J Pharmacogenomics, 5, 123-131. Reference 2 Maekawa et al., 2006, Drug Metab. Pharmacokinet., 21, 109-121. Haplotype Block 2 *1d, *1e Comment 1 Position 2: Reference sequence is AC084732. Position 3: Reference sequence is NT_006204.13. Position 4: cDNA-based numbering. Comment 2 Frequency and haplotype: Reference 2. G in NT_016354.17 Release Date 2003/05/09 Update Date 2006/01/07

---

SQ=Sequencing; TP=Typing; IVS=Intervening Sequence; CYPalleles, http://www.imm.ki.se/CYPalleles/ .